THE WORLD’S FIRST TARGETED THROAT PROBIOTIC1

Targeted probiotic to support a healthy mouth and throat

 

Streptoccocus salivarius K12 (BLIS K12TM) is a world first in a new generation of
targeted oral probiotics, defending the gateway to the body – the mouth and throat.

It works in the oral cavity, it colonises the mouth and throat with good bacteria

Backed by 30 years of research, the BLIS K12 strain has been scientifically2
developed to support a healthy microflora in the oral cavity.

The Oral Microbiome

 

We hear a lot about the gut microbiome, but the oral
microbiome also plays an important role in supporting the
body’s immune defences and overall health. There are
over 700 species of bacteria in the oral cavity alone.

BLIS PROBIOTICS Range

1. Data on file. Refers to commercialisation of Streptococcus salivarius K12
2. Tagg, J R et al. Bacteriological reviews vol. 40,3 (1976): 722-56.